SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius is facing intense volatility as the community debates whether the recent earnings miss and subsequent sell-off represent a fundamental breakdown in the company's growth story or an overreaction that offers a long-term entry point. Investors are actively discussing the impact of inventory rebalancing and SKU optimization, with many remaining divided on whether the stock will face further downward pressure or stabilize as management navigates a transition to a more diversified portfolio.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk is currently facing intense scrutiny and volatility as investors react to mixed signals in the ad-tech sector, with many community members highlighting persistent institutional short positions and skepticism toward management's long-term strategy. Discussions are dominated by concerns over earnings performance and the competitive pressure from major players, with investors debating whether the stock's current price represents a deep-value opportunity or a continued downward trend.

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance Biotherapeutics is trending following a record-breaking second-quarter earnings report, which highlighted significant revenue growth and improved margins that have fueled community optimism. Investors are actively discussing the company's strong commercial execution, potential for upward guidance revisions, and the momentum surrounding its oncology platform, all of which have energized long-term supporters and intensified pressure on short positions.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is currently trending as investors debate the impact of a massive share unlock event, with active community discussion centering on whether current price levels offer a bargain or if further dilution from insiders will drive the stock lower. Traders are closely monitoring the heavy volume and aggressive short-selling activity, with bulls betting on long-term growth and institutional support while bears anticipate downward pressure from the expanding float.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is facing extreme volatility as investors react to a slight revenue miss and softer-than-expected guidance, sparking a heated debate about whether the sell-off is a massive overreaction to a solid growth story or a justified correction for a premium-priced stock. The community is sharply divided, with some investors aggressively buying the dip on the belief that strong cash flow and cleared SEC inquiries make the stock undervalued, while others warn that slowing momentum in ad-tech models justifies the repricing.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded by Keyvan Mohajer, Majid Seyed Emami and James M. Hom on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is experiencing significant market attention following a strong earnings report that featured record revenue growth and raised guidance, fueling intense community discussion about a potential short squeeze. Investors are closely monitoring the stock's high short interest and institutional accumulation, with many debating the sustainability of the rally against broader market volatility and institutional selling pressure.

Dutch Bros, Inc. engages in operating and franchising drive-thru shops that focus on handcrafted beverages. It operates through the Company-Operated Shops, and Franchising and Other segments. The Company-Operated Shops segment consists of coffee shop sales to customers. The Franchising and Other segment is involved in bean and product sales to franchisees and includes the initial franchise fees, royalties, and marketing fees. The company was founded by Travis Boersma and Dane Boersma in 1992 and is headquartered in Tempe, AZ.

Dutch Bros Inc - Ordinary Shares - Class A

Dutch Bros Inc

Dutch Bros is experiencing heightened volatility and intense social media conversation as investors weigh strong consumer demand and rapid store expansion against concerns regarding high valuation multiples and stock-based compensation. Community sentiment is deeply divided, with bulls pointing to robust transaction growth and store footprints, while bears remain cautious of the stock's premium pricing following its recent earnings report.

Oscar Health, Inc. is a healthcare insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health is trending as the stock hits new highs, driven by strong quarterly results and positive guidance that have fueled investor confidence in its growth trajectory. The community is actively debating the company's valuation versus its long-term potential, with many investors focusing on the stock's impressive momentum following its breakout from extended consolidation.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending as investors weigh strong institutional accumulation and positive clinical trial registry updates against persistent frustration over management's silence and the lack of concrete partnership announcements. The community is actively debating the path forward for the COVID-19-Influenza Combination (CiC) program and the long-term potential of the Matrix-M platform, with many analysts highlighting that conviction is building despite stagnant trading volume.

Cardano is a blockchain platform built on academic research that enables smart contracts and decentralized applications while using significantly less energy than traditional cryptocurrencies like Bitcoin.   What sets Cardano apart is its methodical, research-driven approach — every major feature is peer-reviewed by scientists and cryptographers before being added to the network. This careful process aims to create a more secure and stable foundation compared to platforms that prioritize speed over thorough testing. The platform's native cryptocurrency, ADA, is used to send money, pay transaction fees, and participate in network governance.  Cardano uses a proof-of-stake system to process transactions, which works differently from Bitcoin's mining approach. Instead of competing to solve complex puzzles, users can "stake" their ADA — essentially locking it up temporarily — to become validators who verify transactions. The system selects validators based on how much ADA they've staked and for how long, then rewards them with additional ADA for their participation. This approach uses far less energy than traditional mining while keeping the network secure. The platform also features a two-layer design that separates basic payment transactions from smart contract operations, allowing each function to be optimized independently for better performance.   ADA holders can earn staking rewards by locking up their tokens to help secure the network, vote on proposed changes to the platform, and use ADA for international money transfers with lower fees than traditional services.  Cardano was founded in 2017 by Charles Hoskinson, who previously helped create Ethereum. Hoskinson leads Input Output Global (IOG), the technology company that builds and maintains Cardano's core software. The ecosystem operates through three organizations: IOG handles technical development, the Cardano Foundation promotes adoption and standardization, and Emurgo helps businesses integrate blockchain technology into their operations. This structure distributes responsibilities across multiple groups rather than concentrating control in a single entity.   In February 2025, major asset manager Grayscale Investments filed to create an exchange-traded fund (ETF) for Cardano with the U.S. Securities and Exchange Commission, which would allow traditional investors to buy ADA through their regular brokerage accounts without needing to set up cryptocurrency wallets.

Cardano

Cardano is experiencing heightened community interest and volatility as investors debate the potential for a recovery amidst persistent bearish sentiment and concerns over long-term utility. Market participants are actively discussing price targets, the implications of pending regulatory clarity, and recent network upgrades while weighing whether this current period represents a strategic accumulation opportunity or a structural decline.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$AMTM 

A safe play I stroll beleive to be a solid long term play. Which touches on uranium exposer in a very far off way. 

I took this one a little into this year and have seen a whole lotta nothing (we will see if that changes EOY).

imo super safe with decent upside. Happy I bought still despite being up a whopping 1%

Mark W.

StockTwits for iOS

Amentum Holdings Inc.

 

A safe play I stroll beleive to be a solid long term play. Which touches on uranium exposer in a very far off way. 

I took this one a little into this year and have seen a whole lotta nothing (we will see if that changes EOY).

imo super safe with decent upside. Happy I bought still despite being up a whopping 1%